Two years after officially legalizing medical cannabis, Together Pharma of Uganda exported its first grams of medical cannabis to the UK. Together Pharma, which currently supplies Israel with medical cannabis, is the only company growing medical cannabis in Uganda, with a farm spanning 30,000 m² of greenhouses for a reported total production capacity of over 15 tonnes per year.
Two years after officially legalizing medical cannabis, Uganda exported its first grams of medical cannabis to the UK.
For more news like this, download our free cannabis news app.
Via the German company Cantourage and its British subsidiary, the Israeli company Together Pharma, a producer of medical cannabis in Uganda, exported an undisclosed quantity of medical cannabis for the Cantourage Clinic network of clinics.
Cantourage UK will thus offer two medical cannabis flowers with a high THC content and non-irradiated: Glueberry OG® (Gorilla Glue x OG Kush x Blueberry, 17% THC) and Power Plant (19% THC).
To our knowledge, Together Pharma is today the only company growing medical cannabis in Uganda despite many requests. Its Ugandan farm spans around 30,000 m² of greenhouses and has a reported total production capacity of over 15 tonnes per year.
Together Pharma currently mainly supplies Israel with medical cannabis and carried out its first export to Germany at the beginning of the year, already with Cantourage, for an undisclosed quantity.
In a statement on the Uganda deal, Niall Ivers, COO of Cantourage UK, said: “We are delighted to extend our successful partnership with Together Pharma to the UK. Together Pharma is a leader in the Israeli domestic market, with extensive knowledge and international experience in delivering high-quality, high-value medicines to patients. We are confident that introducing these first two varieties will help build a sustainable ecosystem for UK patients.”
Nir Sosinsky, Managing Director of Together Pharma, added: “The extension of our partnership with Cantourage UK is extremely exciting for Together Pharma and is another step in expanding our global reach. It strengthens our position in the UK and Europe while supporting our commitment to the cannabis industry in Uganda, which holds great potential for the country. The UK is an extremely important market for us. We are pleased that our medical-grade cannabis flowers are made available by Cantourage UK and Cantourage Clinic, enabling a reliable supply to benefit patients across the country.”
—
(Featured image by Tom Fisk via Pexels)
DISCLAIMER: This article was written by a third-party contributor and does not reflect the opinion of Hemp.im, its management, staff, or its associates. Please review our disclaimer for more information.
This article may include forward-looking statements. These forward-looking statements generally are identified by the words “believe,” “project,” “estimate,” “become,” “plan,” “will,” and similar expressions. These forward-looking statements involve known and unknown risks as well as uncertainties, including those discussed in the following cautionary statements and elsewhere in this article and on this site. Although the Company may believe that its expectations are based on reasonable assumptions, the actual results that the Company may achieve may differ materially from any forward-looking statements, which reflect the opinions of the management of the Company only as of the date hereof. Additionally, please make sure to read these important disclosures.
First published by Newsweed, a third-party contributor translated and adapted the article from the original. In case of discrepancy, the original will prevail.
Although we made reasonable efforts to provide accurate translations, some parts may be incorrect. Hemp.im assumes no responsibility for errors, omissions, or ambiguities in the translations provided on this website. Any person or entity relying on translated content does so at their own risk. Hemp.im is not responsible for losses caused by such reliance on the accuracy or reliability of translated information. If you wish to report an error or inaccuracy in the translation, we encourage you to contact us.
The DEA has postponed a key hearing on the reclassification of cannabis. The hearing was…
A new California Department of Public Health report has come out with recommendations for THC…
Ontario is investing $31 million over the next three years to enhance efforts against illegal…
Frankfurt and Hanover are launching five-year pilot projects for legal, regulated cannabis sales to adults,…
Italy's Regional Administrative Court suspended the Health Ministry's decree labeling CBD as a narcotic, pending…
This November, five U.S. states will vote on measures related to legalizing recreational or medical…